Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine/MMF vs Cyclophosphamide/Prednisolone in Anti-r-HuEpo PRCA
NCT01288131Phase 3Terminated
- Sponsor
- Chulalongkorn University
- Start
- Jan 2009
- Primary completion
- Jan 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine, mycophenolate mofetil in pure red cell aplasia (PRCA), sponsored by Chulalongkorn University. Started Jan 2009; status: terminated.
02
Drugs
cyclosporinemycophenolate mofetil
03
Conditions
pure red cell aplasia (PRCA)
Beyond the preview
Go deeper on NCT01288131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01288131.